Equity
Preferred Stock Par Value Per Share
Alnylam Pharmaceuticals Preferred Stock Par Value Per Share remained flat by 0.0% to $0.01 in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $0.01 to $0.01. Over 5 years (FY 2020 to FY 2025), Preferred Stock Par Value Per Share shows relatively stable performance with a 0.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
First reportedQ4 2018
Last reportedQ1 2026Apr 30, 2026
Metric ID:
preferred_stock_par_value_per_shareHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
Range$0.01 – $0.01
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak19+ quarters growth
Preferred Stock Par Value Per Share at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's preferred stock par value per share?
- Alnylam Pharmaceuticals (ALNY) reported preferred stock par value per share of $0.01 in Q1 2026.
- How has Alnylam Pharmaceuticals's preferred stock par value per share changed year-over-year?
- Alnylam Pharmaceuticals's preferred stock par value per share decreased by 0.0% year-over-year, from $0.01 to $0.01.
- What is the long-term trend for Alnylam Pharmaceuticals's preferred stock par value per share?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's preferred stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.